RoefaroJMukherjeeSM. Olanzapine-induced hyperglycemic nonketonic coma. Ann Pharmacother2001; 35: 300–2. DOI 10.1345/aph.10178
2.
PetersonGAByrdSL. Diabetic ketoacidosis from clozapine and lithium cotreatment. Am J Psychiatry1996; 153: 737–8.
3.
IsojarviJILaatikainenTJKnipMPakarinenAJJuntunenKTMyllylaVV. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol1996; 39: 579–84.
4.
KrausTHaackMSchuldAHinze-SelchDKuhnMUhrM, Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiatry1999; 156: 312–4.
5.
HallACBrennanAGooldRGCleverleyKLucasFRGordon-WeeksPR, Valproate regulates GSK-3–mediated axonal remodeling and synapsin I clustering in developing neurons. Mol Cell Neurosci2002; 20: 257–70.
6.
NaranjoCABustoUSellersEMSandorPRuizIRobertsEA, A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30: 239–45.
